I agree that this site is using cookies. You can find further informations here.
X
Betts, Keith A.
198  results:
Search for persons X
?
1

Real-world safety of first-line immuno-oncology combination..:

Betts, Keith A ; Gao, Sophie ; Ray, Saurabh.
Future Oncology.  20 (2024)  13 - p. 851-862 , 2024
Link: https://doi.org/10.2217/..
 
?
2

Safety of Upadacitinib in Immune-Mediated Inflammatory Dise..:

Mysler, Eduardo ; Burmester, Gerd R. ; Saffore, Christopher D....
Advances in Therapy.  41 (2024)  2 - p. 567-597 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Clinical outcomes of adjuvant nivolumab in resected stage I..:

Moser, Justin C. ; Bhatia, Shailender ; Amin, Asim...
Cancer Immunology, Immunotherapy.  73 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

Real-World Patterns and Economic Burden Associated With Tre..:

Lee, Scott D ; Betts, Keith A ; Xiaoyan Du, Ella...
Crohn's & Colitis 360.  6 (2024)  2 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
5

Treatment patterns and survival outcomes among androgen rec..:

Narayan, Vivek ; Patel, Miraj Y. ; Teitsson, Siguroli...
Clinical Genitourinary Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Long-Term Temporal Trends of Real-World Healthcare Costs As..:

Du, Ella Xiaoyan ; Betts, Keith A. ; Wang, Travis...
Oncology and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Tu1893 REAL-WORLD RETROSPECTIVE ANALYSIS OF OZANIMOD AND AS..:

Paul, Damemarie ; Nie, Xiaoyu ; Gao, Sophie Y....
Gastroenterology.  166 (2024)  5 - p. S-1457-S-1458 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Tolvaptan and Number Needed to Harm in Autosomal Dominant P..:

Betts, Keith A. ; Nunna, Sasikiran ; Kumar, Retesh..
Kidney Medicine.  6 (2024)  4 - p. 100802 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroeso..:

Sugarman, Ryan ; Betts, Keith A. ; Nie, Xiaoyu..
Clinical Therapeutics.  45 (2023)  11 - p. 1155-1158 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Grade 3/4 Adverse Event Costs of Immuno-oncology Combinatio..:

McGregor, Bradley ; Geynisman, Daniel M ; Burotto, Mauricio...
The Oncologist.  28 (2023)  1 - p. 72-79 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Su1147 ECONOMIC BURDEN OF SUBOPTIMAL TREATMENT WITH CONVENT..:

Horst, Sara N. ; Suryavanshi, Manasi ; Betts, Keith...
Gastroenterology.  164 (2023)  6 - p. S-546 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Impact of benralizumab on asthma exacerbation-related medic..:

Chung, Yen ; Maselli, Diego J. ; Mu, Fan...
Journal of Medical Economics.  26 (2023)  1 - p. 954-962 , 2023
Link: https://doi.org/10.1080/..
 
?
13

Development of a triage algorithm for mild cognitive impair..:

Li, Gang ; Batrla, Richard ; Betts, Keith A....
Alzheimer's & Dementia.  19 (2023)  S23 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
14

Comparative Efficacy of Venetoclax-Based Combination Therap..:

Li, Xue ; Suh, Hae Sun ; Lachaine, Jean...
Value in Health.  26 (2023)  12 - p. 1689-1696 , 2023
Link: https://doi.org/10.1016/..
 
?
15

A Matching-adjusted Indirect Comparison of Nivolumab Plus C..:

McGregor, Bradley ; Geynisman, Daniel M. ; Burotto, Mauricio...
European Urology Oncology.  6 (2023)  3 - p. 339-348 , 2023
Link: https://doi.org/10.1016/..
 
1-15